Here we describe the comprehensive gene expression profiles of each cell type composing normal breast tissue and in situ and invasive breast carcinomas using serial analysis of gene expression. Based on these data, we determined that extensive gene expression changes occur in all cell types during cancer progression and that a significant fraction of altered genes encode secreted proteins and receptors. Despite the dramatic gene expression changes in all cell types, genetic alterations were detected only in cancer epithelial cells. The CXCL14 and CXCL12 chemokines overexpressed in tumor myoepithelial cells and myofibroblasts, respectively, bind to receptors on epithelial cells and enhance their proliferation, migration, and invasion. Thus, chemokines may play a role in breast tumorigenesis by acting as paracrine factors.
Introduction
. Using these approaches, the molecularbased classification of breast cancer has become a reality, and molecular signatures correlating with metastatic behavior and Breast cancer is the most commonly identified and one of the clinical outcome have been identified (Ramaswamy et al., 2003 ; deadliest neoplasms in women in Western countries. The recent Sorlie et al., 2001; van 't Veer et al., 2002; , trend toward improvement in breast cancer mortality rate is 2002) . However, since most of these analyses were performed largely due to increased diagnosis of early stage disease, while using bulk tissue samples that are composed of multiple cell our therapeutic options for advanced stage breast carcinomas types or purified tumor epithelial cells, the specific contribution are still fairly limited. Thus, there is a need to better understand the molecular basis of breast cancer initiation and progression of epithelial and stromal cells to these tumor classifiers and prognostic signatures is unknown. Similarly, in the past decades and to use this knowledge for the design of targeted, molecularbased therapies. In the past few years, newly developed techthe major focus of cancer research has been the transformed tumor cell itself, while the role of the cellular microenvironment nologies such as microarrays and SAGE (serial analysis of gene expression) have enabled us to analyze molecular differences in tumorigenesis has not been widely explored. Early studies demonstrated the ability of stromal tissues to regulate the between normal and cancer cells at a genome-wide level in comprehensive and unbiased ways (Schena et al., 1995; Vel- growth and differentiation state of breast cancer cells (DeCosse
S I G N I F I C A N C E
Despite compelling cell biological studies and histopathological observations incriminating myoepithelial and stromal cells in tumorigenesis, our knowledge of the genes that mediate changes in the tumor microenvironment and interactions among various cell types in breast cancer and their role in tumorigenesis is limited. Similarly, the occurrence and role of genetic changes in stromal cells are undefined. Here, we describe a comprehensive molecular characterization of each cell type composing normal breast tissue and in situ and invasive breast carcinomas. We identified several genes as potential mediators of epithelial-stromal/myoepithelial cell interactions, including the CXCL12 and CXCL14 chemokines. These data should therefore provide a valuable resource for future basic and clinical studies addressing the role of epithelial-stromal/myoepithelial cell interactions in breast cancer. et al., 1973, 1975) , and several recent in vivo and in vitro studies the myofibroblasts using CD10 beads. Several recent studies have demonstrated that the growth, differentiation, invasive bereported that some morphologically distinct myoepithelial cells havior, and polarity of normal mammary epithelial cells and lack CD10 and other myoepithelial cell markers (Zhang et al., breast carcinomas are influenced by surrounding stromal cells 2003). Thus, due to the use of CD10 beads for the isolation of including fibroblasts, myofibroblasts, leukocytes, and myoepimyoepithelial cells, a subset of myoepithelial cells may have thelial cells Radisky et al., 2001;  been excluded from our study. We were not able to identify an Tlsty, 2001 ). In addition, certain histopathological features of antibody that would specifically recognize fibroblasts and allow breast tumors, including lymphocytic infiltration, fibrosis, and their purification; thus, we used the unbound fraction following angio-and lymphangiogenesis, have proven prognostic signifithe removal of all other cell types as a fibroblast-enriched "strocance. Despite these convincing data implicating a role for the mal" fraction. A detailed description of the purification method is tumor microenvironment in breast tumorigenesis, our underdescribed in the Supplemental Data (http://www.cancercell.org/ standing of the genes mediating cellular interactions and paracgi/content/full/6/1/17/DC1). Since this protocol includes secrine regulatory circuits among various cell types in normal and quential enzymatic digestion of the tissue, the possibility that the cancerous breast tissue and their role in breast tumorigenesis expression of some genes could be altered due to the procedure is limited.
cannot be excluded. However, since we were able to verify the In the past few years, the role of the cellular microenviron-SAGE data by alternative methods using unprocessed tissue ment in tumorigenesis has become an intense area of research.
( Figure 3 ), these changes (if any) are likely to be minimal. The This is in part due to studies demonstrating that genetic abnorsuccess of the purification method and the purity of each cell malities, such as loss of heterozygosity (LOH), occur not only fraction were confirmed by performing RT-PCR on a small fracin cancer cells, but in stromal cells as well (Kurose et al., 2001 , tion of the isolated cells using cell type-specific genes ( Figure  2002 ; Lakhani et al., 1998; Moinfar et al., 2000) . However, no 1B). The remaining portion of the cells ‫000,001-000,01ف(‬ cells, genes presumably targeted by these genetic events in stromal depending on the sample) was used for the generation of microcells have been identified; thus, their role in breast tumorigenesis SAGE libraries following previously described protocols (Porter is still unknown. et al., 2001 (Porter is still unknown. et al., , 2003a and for the isolation of genomic DNA to be As a consequence of studies focusing almost exclusively on used for array comparative genomic hybridization (aCGH) and cancer cells, nearly all of the currently used cancer therapeutic single nucleotide polymorphism (SNP) array studies. We have agents target the cancer cells that, due to their inherent genomic generated SAGE libraries from epithelial and myoepithelial cells instability, frequently acquire therapeutic resistance (Rajagopa-(myofibroblasts from invasive tumors), infiltrating lymphocytes, lan et al., 2003) . In part due to frequent therapeutic failures endothelial cells, and fibroblasts (stroma) from one normal during the course of treatment of advanced stage tumors, inbreast reduction tissue, two different DCIS, and three invasive creasing emphasis has been placed on targeting various stromal breast tumors. Not all libraries were generated from all cases cells, particularly endothelial cells, via therapeutic interventions. due to our inability to obtain sufficient amounts of purified cells. Since these cells are thought to be normal and genetically stable,
In addition, we also included a fibroadenoma and a phyllodes they are less likely to develop acquired resistance to cancer tumor in our SAGE analyses. Fibroadenomas are the most comtherapy. Thus, isolating and characterizing each cell type (epimon benign breast tumors that are not considered to progress thelial, myoepithelial, and various stromal cells) comprising nonto malignancy despite genetic changes detected in the stromal malignant and cancerous breast tissue would not only help us (but not epithelial) cells (Amiel et al., 2003) . Phyllodes tumors, to understand the role these cells play in breast tumorigenesis, on the other hand, are rare fibroepithelial tumors that are usually but would likely give us new molecular targets for cancer interbenign but can recur and progress to malignant sarcomas. Inivention and treatment.
tially, phyllodes tumors were considered stromal neoplasms, but recent molecular studies demonstrating (frequently discordant) Results genetic alterations in both epithelial and stromal cells suggests that phyllodes tumors may represent a true clonal co-evolution Purification of all cell types present in breast tissue of malignant epithelial and stromal cells (Sawyer et al., 2000 , To determine the molecular profile of each cell type that, to -2002) . A detailed description of the tissue samples and the gether, compose the breast tissue and to identify autocrine SAGE libraries is included in the Supplemental Data online. and paracrine interactions that may play a role in breast tumor Analysis of the SAGE data confirmed that the cell purification progression, we developed a purification procedure that allows procedure worked well, since several genes known to be spethe isolation of pure cell populations from normal breast tissue cific for a particular cell type were present in the appropriate and from in situ (ductal carcinoma in situ, DCIS) and invasive SAGE libraries. For example, cytokeratins 8 and 19, E-cadherin, breast carcinomas ( Figure 1A ). We utilized cell type-specific cell HIN-1, and CD24 were highly specific for epithelial cells (HIN-1 surface markers and magnetic beads for the rapid sequential only for normal epithelial cells); myofibroblast and myoepithelial isolation of the various cell types. We used the BerEP4 antigen cells demonstrated high levels of smooth muscle actin, various restricted to epithelial cells, the CD45 panleukocyte marker, extracellular matrix proteins including collagens, and matrix and the P1H12 antibody that specifically recognizes endothelial metalloproteinases; and leukocyte libraries had the highest levcells. The CD10 antigen is present in myoepithelial cells and els of several chemokines and lysozyme (Table 1 and Supplemyofibroblasts, but also in some leukocytes. Thus, to minimize mental Table S1 ). In general, SAGE libraries prepared from the the crosscontamination of these different cell types, in the case same cell type purified from different tissue samples were highly of normal (N-MYOEP-1) and DCIS breast tissue, myoepithelial similar to each other, although there were differences as well, cells were isolated from organoids (breast ducts), while in invasive tumors we first removed the leukocytes prior to capturing likely due to variability among patients and also slight variability RT-PCR analysis of each cell fraction isolated from DCIS-7 using known cell type-specific genes to confirm the purity of the cells and integrity of the mRNA. MME (CD10) is highly specifically expressed in CD10 ϩ myoepithelial cells and myofibroblasts, PTPRC (CD45) in leukocytes, and CDH5 (endothelial cadherin) in endothelial cells. Although ERBB2 is not an absolutely epithelial cell-specific gene, its abundance is highest in luminal epithelial cells. PCR was performed at 25, 30, and 35 cycles. Genes expressed at equal levels in all cell types; ␤-actin (ACTB) and ribosomal protein L19 (RPL19) were used as controls. in the purification procedure itself (see Supplemental Data for (Tables 1 and 2 and Supplemental Tables S1-S15 ). Genes were defined as specific for a particular cell type if the average tag more details).
number in all the SAGE libraries generated from the selected cell type was statistically significantly (p Ͻ 0. , 1996) . Using these criteria, Tables S3, S5 , S7, S9, and S11). Several of these genes have previously been sins F, K, and L, MMP2, and PRSS11), protease inhibitors (thrombospondin 2, SERPING1, cystatin C, and TIMP3), and described as being specific for a particular cell type, such as keratins 8 and 19 for epithelial cells, keratins 14 and 17 for many different collagens were highly upregulated in DCIS myoepithelial cells, suggesting a role for these cells in extracellular myoepithelial cells, and chemokines and chemokine receptors for leukocytes (Page et al., 1999) , but the cell type-specific matrix remodeling ( Table 2) . expression of the majority of the genes has not been documented. The majority of the transcripts corresponding to these Analysis of the genotype of epithelial, myoepithelial, and stromal cells cell type-specific SAGE tags encode known genes, but a significant fraction are uncharacterized ESTs or currently have no
To determine if the dramatic gene expression changes observed in tumor myoepithelial and stromal cell types could be due to cDNA match ‫%01ف(‬ of the tags on average belong to each of these last two groups). The only exceptions were tags most underlying genetic alterations, we first performed aCGH analysis of epithelial and myoepithelial cells and of myofibroblasts from abundant in stroma, since in this group 25/117 tags (21%) had no database match, suggesting that they correspond to pretwo DCIS (DCIS-6 and -7) and one invasive breast carcinoma (IDC7) used for SAGE. As expected, we detected numerous viously unidentified transcripts.
Next, using the SAGE tags most abundant in (417 tags) or chromosomal gains and losses in the tumor epithelial cells, while no changes were detected in myoepithelial cells and myomost highly specific for (63 tags) each of the five cell types, we performed clustering analysis of all 27 SAGE libraries using a fibroblasts (Figures 2A and 2B) . Similarly, no genetic changes were detected in epithelial and myoepithelial cells isolated from new Poisson model-based K-means algorithm (PK algorithm, Supplemental Data; Cai et al., 2004) to delineate similarities and normal tissue adjacent to the tumors ( Figure 2A ). These data suggest that although nonepithelial cells in breast tumors are differences among the samples ( Figures 1C and 1D ). In addition, we also performed clustering analysis of the SAGE libraries phenotypically distinct from their normal counterparts, genetic changes detectable by aCGH appear to be limited to cancer using each of the cell type-specific gene sets (Supplemental Figures S1 and S2 ). The PK clustering method orders the samepithelial cells. However, since array CGH is thought to be more sensitive for the detection of copy number gains than losses ples according to their relatedness. For example, using the 63 most highly cell type-specific SAGE tags, we obtained a division and previous studies demonstrated LOH in stromal cells, we applied another technology, SNP arrays, for the analysis of of the 27 SAGE libraries according to cell types, and within each cell type subgroup, the DCIS samples were located between isolated epithelial and stromal cells from a set of breast tumors. As expected, cancer epithelial cells from all but one invasive normal breast tissue and invasive breast cancer SAGE libraries ( Figure 1D ). This result indicates that not only tumor epithelial breast tumor demonstrated numerous LOH on nearly all chromosomes, while myofibroblasts and other stromal cells from cells, but also other cell types in the tumor, are different from their corresponding normal counterparts. Since these differthe same tumors appeared to be mostly normal ( Figure 2C and Supplemental Figure S3 ). Clustering analysis based on the ences are already pronounced at a pre-invasive (DCIS) tumor stage, they suggest a role for stromal changes not only in tumor inferred LOH data clearly divided the samples into two major groups, the tumor epithelial and stromal cells from different invasion and metastasis, but also in the earlier steps of breast tumorigenesis.
cases demonstrating more similarity to each other than to their corresponding other cell type ( Figure 2C ). The only exception Based on our SAGE data, we found that the most consistent and dramatic gene expression changes occur in myoepithelial was epithelial cells from IDC10 (a low-grade estrogen receptorpositive tumor) that did not appear to have major genetic cells. More than 300 genes were differentially expressed at p Ͻ 0.002 in both DCIS myoepithelial libraries, and interestingly, a changes (the purity of the tumor epithelial cells was confirmed by RT-PCR, data not shown), while in the phyllodes tumor, the significant fraction of these genes (89 out of 245 characterized genes) encode secreted or cell surface proteins, suggesting stroma had numerous genetic alterations with much fewer LOH events detected in the epithelial cells. We did not detect signifiextensive abnormal paracrine interactions between myoepithelial and other cell types (Supplemental Table S5 ). Myoepithelial cant LOH in the three fibroadenomas analyzed or in the one LCIS (lobular carcinoma in situ) case. Two nonepithelial samples cells are thought to be derived from bipotential stem cells that also give rise to luminal epithelial cells, although recently another (I-MYOFIB-8 and I-STR-13) had a few areas where 2-5 adjacent SNPs exhibited LOH ( Figure 1C ), but careful examination of progenitor has been identified that can differentiate only into myoepithelial cells (Bocker et al., 2002; Dontu et al., 2003) . The these SNPs individually suggested that these LOH calls are likely due to poor hybridization results. In order to resolve this function of myoepithelial cells and their role in breast cancer are not well understood, but myoepithelial cells have been shown to issue, we amplified and sequenced eight of these ambiguous As depicted in the figure in the case of SNP rs952018, the I-MYOFIB-8 sample had both "A" and "G" peaks just like the N-EPI-I7 sample, proving the retention of both alleles, while the I-LEU-14 sample was homozygous for the "G" allele and the N-for IDC11 (normal DNA corresponding to tumor IDC11) was homozygous for the "A" allele. Similarly in the case of SNP rs952018, the I-MYOFIB-8 sample had both T and C peaks just like the N-for IDC15 (normal DNA corresponding to tumor IDC15), while the N-EPI-I7 and I-EPI-15 were both homozygous for the "C" allele.
SNPs from these two stromal samples (I-MYOFIB-8 and I-STREvaluation of gene expression by immunohistochemistry and mRNA 13) together with several controls, where the SNP results clearly depicted heterozygous or homozygous alleles. In all seven in situ hybridization The generation of the SAGE libraries involved the in vitro purificases in which high-quality sequencing results were obtained, we found no evidence of LOH in either of these two ambiguous cation of the cells that could potentially alter the in vivo gene expression patterns, although prior SAGE data from several stromal samples ( Figure 2D ). laboratories suggest that these changes are likely to be minimal (Porter et al., 2003a (Porter et al., , 2003b St Croix et al., 2000) . However, in order to further investigate the expression of selected genes at the cellular level in vivo, we performed immunohistochemical analyses and mRNA in situ hybridization in a panel of DCIS and invasive breast tumors (including tumors used for SAGE as well as additional cases). In addition, the cell type specificity of some genes was verified by RT-PCR in the samples used for SAGE (data not shown). Immunohistochemical analysis confirmed that two genes, IL-1␤ and CCL3 (MIP1␣), are highly expressed in leukocytes infiltrating DCIS, but not normal breast tissue, whereas the PTPRC (CD45) panleukocyte marker was expressed in both cases ( Figure 3A) . Despite the similar number of total leukocytes in invasive tumors, the frequency of IL-1␤ and CCL3-positive leukocytes was much lower than in DCIS, suggesting that in situ and invasive breast carcinomas may be immunologically dissimilar. mRNA in situ hybridization determined that in DCIS tumors, the expression of PDGF receptor ␤-like (PDGFRBL), cathepsin K (CTSK), and CXCL12 was localized to myofibroblasts as determined by smooth muscle actin (ACTA2) staining, CXCL14 was expressed only in myoepithelial cells, while TIMP3, cystatin C (CST3), and collagen triple helix repeat containing 1 (CTHRC1) were expressed in both myoepithelial cells and myofibroblasts. In invasive tumors, all seven genes were expressed in myofibroblasts. No signal was detected in normal breast tissue nor with the sense probes ( Figure  3B , Supplemental Figure S4 , and data not shown). Interestingly, although in DCIS tumors we detected CXCL14 expression only in myoepithelial cells, in some (4/9) invasive breast carcinomas, the expression of CXCL14 was restricted to the tumor epithelial cells (Figures 3B and 4A) . Similarly, some breast cancer cell lines expressed high levels of CXCL12 or CXCL14 in vitro, suggesting that during tumor progression a paracrine factor may be converted into an autocrine one due to its upregulation in the tumor epithelial cells ( Figure 4B ). Interestingly, all CXCL14-positive invasive ductal carcinomas and even the CXCL14 expressing breast cancer cell line (UACC812) were obtained from young, premenopausal patients (average age of onset 39 years), suggesting a possible association of CXCL14 expression with hormone levels or clinico-pathologic characteristics of the tu- or paracrine factors in breast tumors, we investigated which cell types appear to have receptors for these chemokines in vivo in primary breast tissue. The signaling receptor for CXCL12 is CXCR4, which is known to be widely expressed in various (data not shown). The signaling receptor of CXCL14 is unknown, lymphoid as well as a variety of epithelial cells (Gerard and but cell surface ligand binding experiments have suggested the Rollins, 2001). We confirmed the expression of CXCR4 in presence of a putative CXCL14 receptor on monocytes and B lymphoid and breast epithelial cells using immunohistochemiscells, suggesting that its receptor is not likely to be CXCR4 try, while SAGE data indicated that its expression is increased in invasive tumors compared to DCIS and normal breast tissue (Kurth et al., 2001; Sleeman et al., 2000) . To determine if a CXCL14 binding cell surface protein(s) is also present on breast CXCL14 has similar effects, we tested the effect of conditioned medium containing AP-CXCL14 on the growth of MDA-MB-231 cancer cells, we generated an alkaline phosphatase-CXCL14 (AP-CXCL14) fusion protein to be used as a ligand in receptor and MCF10A cells, while its effect on cell migration and invasion was investigated in MDA-MB-231 cells. Conditioned medias binding assays. Conditioned media of AP-CXCL14 or control AP expressing cells was then used as an affinity reagent to stain of cells transfected with AP alone and CXCL12 were used as negative and positive controls, respectively. Similar to CXCL12, normal and cancerous mammary tissue sections including the DCIS tumors used for SAGE. Blue staining indicated the pres-CXCL14 enhanced the proliferation of MDA-MB-231 and MCF10A cells and the migration and invasion of MDA-MB-231 ence of a CXCL14 binding protein in certain leukocytes and breast epithelial cells ( Figure 5A ). These results suggest the cells ( Figures 5C and 5D , and data not shown). The concentration of AP-CXCL14 was 2-30 nM in these experiments, which presence of a cell surface CXCL14 binding protein(s) in cancerous and normal mammary epithelial cells and are consistent is similar to the concentration required by several chemokines, including CXCL12, to exert biological effects. The same results with a paracrine mechanism of CXCL14 action in the breast. To test further the binding characteristics of AP-CXCL14, we were obtained in cell migration and invasion assays using CXCL14-AP (C-terminal AP-tag) and CXCL14-HA (C-terminal performed in vitro ligand binding assays using various cell lines. Low-level AP-CXCL14 binding was detected in all cell lines HA-tag) fusion proteins ( Figure 5D and data not shown); thus, the observed effects are not likely to be due to the position or tested, including MDA-MB-231 and MDA-MB-435 breast cancer and MCF10A immortalized mammary epithelial cells (data identity of the epitope tag. Preliminary results using recombinant CXCL14 protein and CXCL14 expressing adenovirus demonnot shown). To further characterize the AP-CXCL14-putative CXCL14 receptor interaction, we performed more detailed bind- used for SAGE ( Figure 5E ). In both cases, epithelial cells adjaDiscussion cent to the myoepithelial cell layer were more frequently positive for Ki67 than tumor epithelial cells in other parts of the ducts.
Epithelial-mesenchymal interactions are known to be important for the normal development of the mammary gland and to play This result suggests that tumor epithelial cells may receive paracrine signals from adjacent myoepithelial cells that enhance a role in breast tumorigenesis (Bissell et al., 2002; Coussens and Werb, 2002; Kenny and Bissell, 2003; Radisky et al., 2001 ; their proliferation, although other reasons for this intraductal location-dependent proliferation difference cannot be excluded. Shekhar et al., 2003; Tlsty, 2001; Tlsty and Hein, 2001; Wiseman and Werb, 2002) . Early studies demonstrated that the normal Correlating with this, a recent study described that the gene expression profile of tumor epithelial cells located at the periphmammary microenvironment is capable of "reverting" the neoplastic phenotype of breast cancer cells by inducing cellular ery and the center of DCIS ducts is significantly different (Zhu et al., 2003) .
differentiation (DeCosse et al., 1973 (DeCosse et al., , 1975 , suggesting that cancer cells can thrive only in a distorted environment or have isolated, uncultured myoepithelial cells from normal breast tissue also demonstrated the high expression of laminin, tenascin, to become independent of extracellular signals. The contribution of genetic host factors to tumor initiation, progression, and angithrombospondin, and PAI-1 binding protein. However, the expression of these genes was downregulated in DCIS myoepitheogenesis also support a role for nonepithelial cells in carcinogenesis (Hunter, 2004; Rohan et al., 2000) . This was dramatically lial cells similar to that of cytokeratins 7, 14, and 17, oxytocin receptor, and tropomyosin, suggesting that DCIS myoepithelial illustrated by the finding that inactivation of TGF-␤ type II receptor in stromal fibroblasts led to prostate and gastric epithelial cells are phenotypically altered and less differentiated than normal myoepithelial cells. Keeping with this, several recent studies neoplasia (Bhowmick et al., 2004) . Similarly, a recent finding demonstrating that mammary tumors only formed in cleared described a lack of commonly used myoepithelial markers (including CD10 and SMA) in a subset of morphologically distinct mammary fat pads of rats treated with carcinogen, regardless of whether the injected epithelial cells were treated with carcinogen myoepithelial cells, suggesting that myoepithelial cells may also be subject to pathological alterations . Morein vitro, also emphasizes the importance of stromal alterations in the initiating steps of breast cancer (Maffini et al., 2004) .
over, in support of a role for myoepithelial cells in breast tumor progression, it was recently reported that DCIS tumor epithelial Numerous in vitro and in vivo studies using diverse experimental systems have demonstrated that the growth, survival, polarity, cells adjacent to a disrupted myoepithelial cell layer are molecularly and genetically different from their more distant counterand invasive behavior of breast cancer cells can be modulated by myoepithelial and various stromal cells, and several genes parts .
Myofibroblasts are stromal fibroblasts with features of both have been implicated to play an important role in this process (Bissell et al., 2002; Coussens and Werb, 2002; Deugnier et al., myoblasts (e.g., expression of smooth muscle actin) and fibroblasts that have been implicated in breast cancer invasion, ex-2002; Elenbaas and Weinberg, 2001; Gudjonsson et al., 2002; Kenny and Bissell, 2003; Radisky et al., 2001; Shekhar et al., tracellular matrix remodeling, wound healing, and chronic inflammation (De Wever and Mareel, 2003; Gabbiani, 1999; Sternlicht and Barsky, 1997; Tlsty, 2001; Tlsty and Hein, 2001; Wiseman and Werb, 2002) . However, comprehensive moSchurch, 1999). The cell type of origin of myofibroblasts is not conclusively established. Certain cytokines can induce (TGF-␤) lecular analysis of all cell types that compose normal human mammary breast tissue and breast carcinomas has not been or inhibit (IFN-␥) the transformation of fibroblasts into myofibroblasts in vitro (De Wever and Mareel, 2003; Tanaka et al., performed. With the aim of delineating epithelial-stromal/myoepithelial 2003), while PDGF-B stimulates the proliferation of fibrocytes and their conversion into myofibroblasts in vivo (Oh et al., 1998) . cell interactions at the molecular level, we determined the comprehensive gene expression and genomic profiles of epithelial, Isolation of various stromal and epithelial cells from breast tumors and their coculturing in vitro demonstrated that cancer myoepithelial, and stromal cells in normal breast tissue and in situ and invasive breast carcinomas. Our results confirm at the epithelial cells can induce the expression of myofibroblast markers in a subset of fibroblasts (Ronnov-Jessen et al., 1995) . Howmolecular level that the cellular microenvironment is dramatically different between normal breast tissue and breast carcinoever, the finding that only a small fraction of fibroblasts were transformed into myofibroblasts (Ronnov-Jessen et al., 1995) mas and that this is already evident at the in situ carcinoma stage. Based on our gene expression data, we determined that raises the question of whether myofibroblasts could be derived from specific stem cells that are normally present in the breast the most dramatic and consistent changes occur in myoepithelial cells and myofibroblasts and the majority of the differentially or in the bone marrow and are growth stimulated or recruited by adjacent cancer epithelial cells. Recent data both in animal expressed genes encode secreted and cell surface proteins (Tables 1 and 2 and Supplemental Tables S2 and S5 ). Since models and human breast tumors support the hypothesis that at least a subset of cancer-associated myofibroblasts is derived previous data also implicated these two cell types in breast tumor progression, particularly in the transition of in situ to from circulating bone-marrow derived cells (Chauhan et al., 2003; Ishii et al., 2003) . Our finding that the gene expression invasive carcinomas (Alpaugh et al., 2000; Barsky, 2003; Chauhan et al., 2003; Nguyen et al., 2000; Shao et al., 1998 ; Sternlicht profiles of myofibroblasts isolated from different invasive breast carcinomas are highly similar also suggest their common cell and Barsky, 1997; Sternlicht et al., 1997; Walter-Yohrling et al., 2003) , we mainly focused on tumor myoepithelial cells and type of origin. Two genes highly expressed in tumor myoepithelial cells myofibroblasts and the genes expressed by them.
Myoepithelial cells play a major role in the formation of the and myofibroblasts encoding chemokines CXCL12 and CXCL14 were particularly interesting due to the recently demonstrated basement membrane and lactation due to their expression of type IV collagen, laminin, smooth muscle actin, and oxytocin role of chemokines and chemokine receptors in cancer cell growth, invasion, and metastasis (Barbero et al., 2002; Chen et receptor (Gudjonsson et al., 2002; Murrell, 1995) . They also have been suggested to suppress breast cancer cell growth, al., 2003; Hall and Korach, 2003; Kang et al., 2003; Muller et al., 2001; Scotton et al., 2002) . CXCL12 has been previously invasion, and angiogenesis via shedding of CD44 and expression of protease inhibitors (Alpaugh et al., 2000; Barsky, 2003;  implicated in breast cancer metastasis (Kang et al., 2003; Muller et al., 2001 ), but its high expression in DCIS (a pre-invasive Xiao et al., 1999) . On the other hand, myoepithelial cells are also important for the survival, differentiation, and polarity of tumor) myofibroblasts suggests that it might have additional roles in the earlier stages of breast tumorigenesis. Correlating normal luminal epithelial cells (Gomm et al., 1997a (Gomm et al., , 1997b . Proteomic and mRNA expression profiling of short-term culwith this hypothesis, CXCL12 was recently identified as a transcriptional target of the estrogen receptor that mediates estrotured myoepithelial cells and myoepithelial cell lines, respectively, gave a glimpse of the molecular basis for the tumor and gen-induced proliferation of breast cancer cells (Hall and Korach, 2003) . Relatively little is known about the CXCL14 invasion suppressor role of normal myoepithelium (Barsky, 2003; Page et al., 1999) . Our SAGE-based profiling of freshly chemokine despite the fact that it was independently identified by multiple labs using different approaches. The high expression could be due to the use of different technologies and apof CXCL14 in inflammatory cells in multiple cancer types and proaches. All the studies that described LOH in cancer stroma its selectivity to monoctyes may suggest a role in macrophage analyzed a few polymorphic markers and a fairly small populadevelopment (Frederick et al., 2000; Hromas et al., 1999 ; Kurth tion of stromal cells isolated by microdissection from the same et al., 2001; Sleeman et al., 2000) . Although the receptor for area adjacent to tumor epithelial cells, while we analyzed all the CXCL14 has not been identified, the induction of calcium mobilistromal cells from the tumor and used comprehensive genomezation by recombinant CXCL14 in monocytes suggests that wide SNP arrays. Thus, if the stromal cells are highly heterogesimilar to other chemokines, it is also likely to signal via a G neous with respect to genetic alterations, these changes can protein-coupled receptor. Our preliminary results demonstrating be detected only if relatively few cells from the same area of intracellular calcium flux in MDA-MB-231 breast cancer cells the tumor are analyzed. However, in our view this argues against also support this hypothesis.
the hypothesis that the genetic changes in the stroma are seIn addition to phenotypic alterations, several recent studies lected for and thus play a major role in tumorigenesis. described genetic changes (including LOH and mutations in In summary, this study provides a comprehensive molecular tumor suppressor genes) in stromal cells adjacent to breast characterization of each cell type composing normal breast cancer cells (Kurose et al., 2001 (Kurose et al., , 2002 Lakhani et al., 1998;  tissue and in situ and invasive breast carcinomas. The genes Moinfar et al., 2000; Wernert et al., 2001 ). Loss of heterozygosity described here should therefore provide a valuable resource for at several loci has also been demonstrated in normal-appearing future basic and clinical studies addressing the role of epithelialepithelial cells adjacent to breast carcinomas and short-term stromal cell interactions in breast and other cancer types. The cultured luminal and myoepithelial cells (Deng et al., 1996 ; Forsti availability of specific chemokine receptor inhibitors and preclinet al., 2001; Lakhani et al., 1999; Moinfar et al., 2000) . In several ical studies demonstrating dramatic tumor and metastasis supcases, the tumor epithelial and stromal cells had discordant pressive effects using CXCR4 inhibitors in brain and breast genetic changes, suggesting a clonal co-evolution for these two tumors (Rubin et al., 2003; Tamamura et al., 2003) provide a cell types. Moreover, due to the low probability of two adjacent proof of principle that therapeutic targeting of chemokines is a cells simultaneously acquiring genetic changes, this would also promising new opportunity for the treatment of breast carcisuggest that breast cancer epithelial and stromal cells may be nomas. derived from a common stem cell and then undergo a divergent quent genetic changes we identified in the tumor epithelial cells frozen on dry ice, and stored at Ϫ80ЊC until use or were processed for (1q, 8q, 17q, and 20q gain, and 6q, 8p, 10q, 12q , and 17p LOH), purification as described below. All human tissue was collected using protoboth in DCIS and invasive tumors, were in agreement with that cols approved by the Institutional Review Boards. We purified all the cell of prior studies (Nishizaki et al., 1997; Waldman et al., 2000) .
types from 2 different normal reduction mammoplasty tissues, 2 different
The one tumor DNA sample (IDC10) that appeared to be devoid DCIS, and 13 different invasive ductal carcinomas. Due to technical difficulof significant LOH was obtained from a low-grade estrogen and ties (insufficient number of cells), we were not able to generate SAGE libraries from each cell type of each tissue used for purification. In addition, selected progesterone receptor-positive, HER2-negative breast tumor.
cell types were isolated from a few additional normal and DCIS samples.
The lack of gross chromosomal changes in this tumor is unlikely
The detailed protocol used for the purification of all cell types is included to be due to technical issues, but potentially reflects a special FA, PHY) arrays, and direct sequencing of specific SNPs), we detected IN) , Lipofectamine, or Lipofectamine 2000 (LifeTechnologies, Rockville, MD) to be used for mRNA in situ hybridization were generated by PCR amplificareagents. We performed in vivo and in vitro ligand binding assays on primary tion of a 300-500 bp region of the 3ЈUTR and subcloning the fragments into tissues and cell lines using AP-CXCL14 essentially as described (Flanagan pZERO1.0 (Invitrogen) . The identity of the subcloned PCR products was and Leder, 1990; Porter et al., 2003b) . Briefly, we fixed frozen sections of confirmed by sequencing, and the resulting plasmids were used for the various human specimens, incubated with either AP-CXCL14 fusion protein generation of digitonin-labeled riboprobes essentially as described (Porter or AP control conditioned medium, rinsed, and then incubated with AP et al., 2003a) . mRNA in situ hybridizations and immunohistochemistry were substrate forming a blue/purple precipitate. For in vitro assays we incubated performed as described or as recommended by the antibody supplier (Porter cells in suspension with conditioned media containing either AP alone or et al., 2003a). Mouse monoclonal antibodies for IL1␤ and CCL3 were pur-AP-CXCL14 fusion protein, rinsed, and then assayed for bound AP activity. chased from R&D, while anti-CD45 and anti-Ki67 mouse monoclonal antiTo determine the effect of CXCL14 on cell growth, we plated MDA-MB-231 bodies were obtained from DAKO.
and MCF10A cells (4000 cells/well in a 24-well plate) and grew them in conditioned media containing AP or AP-CXCL14. Conditioned media were Array comparative genomic hybridization generated by transfecting 293 cells with pAP-tag5 or pAP-CXCL14 plasmids cDNA array comparative genomic hybridization using Agilent (Palo Alto, and growing them in McCoy's medium supplemented with 10% FBS (to be California) arrays were performed by the Belfer Genome Center at the Danaused for MDA-MB-231 cells) or in MCF10A media (American Type Culture Farber Cancer Institute. Genomic DNA was digested with DpnII and random Collection, Manassas, VA, to be used in MCF10A cells). Cells were counted prime labeled according to standard protocols with slight modifications (3 wells/time point) on days 1, 2, 4, 6, and 8 after plating. We used 10 nM (Pollack et al., 1999) . (For a detailed protocol, see http://genomic.dfci.harvard.
CXCL12 in MDA-MB-231 cells as positive control. The experiment was edu/array_cgh.htm.) Labeled DNAs were hybridized to human cDNA mirepeated three times. In order to determine if CXCL14 binding to breast croarrays containing 12,814 unique cDNA clones (Agilent Technologies, Hucancer cells has an effect on cell migration and invasion, we tested the ability man 1 clone set). Among these clones, approximately 9,420 unique map of conditioned medium containing AP-CXCL14 or pCDNA3.1 expressing HApositions were found for 12,020 unique GenBank sequences. The median tagged CXCL14 to induce the migration and invasion of MDA-MB-231 cells interval between cDNAs is 100.1 kilobase, 92.8% of intervals are less than using BIOCOAT Matrigel invasion chambers essentially as described (Muller 1 megabase, and 98.6% are less than 3 megabases. The density of coverage et al., 2001) . For invasion assays, we plated 2.5 ϫ 10 4 cells/well and assayed is closely correlated with gene density. Following extensive QA analysis, 24 hr later, while for migration assays we used 1.25 ϫ 10 4 cells/well and fluorescence ratios of scanned images of the arrays were calculated and determined cell numbers 12 hr later. Conditioned medium of cells transfected the raw array CGH profiles were processed to identify statistically significant with pAP-Tag5 or pCDNA 3.1 empty vectors were used as negative control. transitions in copy number using a segmentation algorithm that employs permutation to determine the significance of change points in the raw data. Acknowledgments By mode centering this segmented data set, we defined gains and losses as Log2 signal ratio of greater than or equal to ϩ0.13 or Ϫ0.13, respectively, We thank Gabriela Lodeiro and Ruth Gomes for their help with the acquisition and amplification and deletion as a ratio greater than 0.52 or less than Ϫ0.58, of tumor samples and Drs. Barrett Rollins and Myles Brown for critically respectively (e.g., 97% or 3% quantiles). Statistical analysis of the aCGH data reading the manuscript. This work is funded in part by NIH (NCI-CGAP will be described in detail elsewhere (Brennan et al., 2004) . Segmentation SAGE and SPORE grant P50 CA89393-01 to K.P. and NRSA Fellowship of aCGH profiles was performed by changepoint identification algorithm 5F32CA94788-02 to D.P.) and DOD (grant DAMD 17 01 1 0221 to M.A.). provided by Adam Olshen and E.S. Venkatraman (Lucito et al., 2003) .
W.R.S. and K.P. receive research support from and are consultants to the Novartis Institutes for Biomedical Research. K.P. is a consultant to GenPath Single nucleotide polymorphism array analysis Pharmaceuticals, Inc. SNP array hybridizations were performed by the Dana-Farber Microarray Core using Affymetrix 11K XbaI SNP arrays and protocols recommended by Affymetrix (Santa Clara, CA). These arrays contain probes for both alleles at 11,565 SNP loci, with mean and median intermarker distances of 209 kb (Affymetrix GeneChip 5.0) was used to make allele calls for all loci. These data were then analyzed using dChipSNP (Lieberfarb et al., 2003; Lin et al., References 2004) . Loci that were heterozygous (AB call) in normal epithelium or leukocytes but homozygous (AA or BB call) in the test tissue were identified as Alpaugh, M.L., Lee, M.C., Nguyen, M., Deato, M., Dishakjian, L., and Barsky, potentially having undergone LOH. Some of these potential LOH events S.H. (2000). Myoepithelial-specific CD44 shedding contributes to the antireflect genotyping error, but serial events among neighboring loci along a invasive and antiangiogenic phenotype of myoepithelial cells. Exp. Cell Res. chromosome likely reflect true regional LOH. Regions of statistically likely 261, 150-158. LOH were delineated according to a Hidden Markov Model analysis; the Amiel, A., Kaufman, Z., Goldstein, E., Bruchim, R.B., Kidron, D., Gaber, E., detailed method will be described elsewhere. Two samples (LCIS and FA) and Fejgin, M.D. (2003) . Application of comparative genomic hybridization had no normal reference counterparts. For these, regions of LOH were in search for genetic aberrations in fibroadenomas of the breast. Cancer inferred when a stretch of consecutive homozygous loci exceeded what Genet. Cytogenet. 142, 145-148. would be expected by chance alone. Again, a Hidden Markov Model analysis was used, assigning a marginal probability of heterozygosity of 0.37 to Barbero, S., Bajetto, A., Bonavia, R., Porcile, C., Piccioli, P., Pirani, P., correspond to the actual rate found in these SNPs (Matsuzaki et al., 2004) Ravetti, J.L., Zona, G., Spaziante, R., Florio, T., and Schettini, G. (2002) . and a transition probability between consecutive SNPs proportional to the Expression of the chemokine receptor CXCR4 and its ligand stromal cellgenetic distance between them (Lander and Green, 1987) . A detailed dederived factor 1 in human brain tumors and their involvement in glial proliferascription of the method will be presented in a forthcoming study (M. Lin, tion in vitro. Ann. N Y Acad. Sci. 973, 60-69. R.B., X. Zhao, M. Meyerson, C. Li, and W.R.S., unpublished data). Samples Barsky, S.H. (2003) . Myoepithelial mRNA expression profiling reveals a comwere clustered hierarchically as previously described (Lin et al., 2004) , based mon tumor-suppressor phenotype. Exp. Mol. Pathol. 74, 113-122. upon LOH calls in all statistically likely regions of LOH in all chromosomes. Bhowmick, N.A., Chytil, A., Plieth, D., Gorska, A.E., Dumont, N., Shappell, Ligand binding, cell growth, migration, and invasion assays S., Washington, M.K., Neilson, E.G., and Moses, H.L. (2004) . TGF-beta We generated N-terminal or C-terminal alkaline phosphatase (AP) CXCL14 signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851. fusion proteins using the AP-TAG-5 expression vector (GenHunter, Nashville,
